Navigation Links
Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
Date:3/27/2013

ther than as the primary cause of the lesions.

Oral mucositis is a subpopulation of approximately 90,000 patients in the US, with a comparable number in Europe.  Oral mucositis almost always occurs in patients with head and neck cancer treated with radiation therapy (>80% incidence of severe mucositis) and is common (40-100% incidence) in patients undergoing high dose chemotherapy and hematopoietic cell transplantation, where the incidence and severity of oral mucositis depends greatly on the nature of the conditioning regimen used for myeloablation.

About Soligenix, Inc.

Soligenix is a clinical stage biopharmaceutical company developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics. Soligenix is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including pediatric Crohn's disease (SGX203), acute radiation enteritis (SGX201) and chronic Graft-versus-Host disease (orBec®), as well as developing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis.  

Through its BioDefense Division, Soligenix is developing countermeasures pursuant to the Biomedical Advanced Research and Development Authority (BARDA) Strategic Plan of 2011-2016 for inclusion in the US government's Strategic National Stockpile. Soligenix's lead biodefense products in development are a recombinant subunit vaccine called RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin and VeloThrax™, a vaccine against anthrax exposure. RiVax™ has been shown to be well tolerated and immunogenic in two Phase 1 clinical trials in healthy volunteers. Both RiVax™ and VeloThrax™ are currently the subject of a $9.4
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
3. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
4. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
5. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
8. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
9. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
10. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
11. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... You,re visiting the dentist for what you ... or she says you need a root canal. Though ... have several questions and feel apprehensive about your upcoming ... nothing to worry about. The Pennsylvania Dental Association (PDA) ... anxiety the public may have surrounding this common procedure ...
(Date:12/19/2014)... Breckenridge Pharmaceutical, Inc. announced today that it ... Pvt. Ltd. ( Hyderabad, India ) under ... ANDAs.  Under the terms of the agreement, MSN will ... for the U.S. market, and Breckenridge will market and ... have agreed to develop an oral antibiotic with current ...
(Date:12/19/2014)... 19, 2014 In today,s increasingly global ... presence to reflect the needs of a global ... meet the needs of key stakeholders while recognizing ... According to recent research by benchmarking firm, ... participating companies averaged more than $100,000 in annual ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Building a Best-in-Class Pharma Global Brand Website 2
(Date:12/19/2014)... 2014 Sub Zero Ice Cream is partnering ... drive Sunday the 28th from 2pm-6pm at the Expo Center ... in Sarasota, FL. , Inquiries regarding time slots and signing ... in the donating process, Sub Zero Ice Cream & Yogurt ... ice cream. , About Sub Zero Ice Cream & Yogurt ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles from Narconon ... lake with more than 600 miles of shoreline. ... more than 3,000 residents, hosted its annual old-fashioned holiday ... December. , Featuring Santa, Christmas lights and parade floats, ... Street. Narconon Arrowhead’s parade float participated in this ...
(Date:12/19/2014)... parents that buying an older car for their teens may put ... killed in the United States between 2008 and 2012 were driving ... important safety features that are available on newer cars, the study ... in cars at least six years old, 34 percent were in ... 11 to 15 years old, and 17 percent were in cars ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Dense bunches of bacteria called biofilms ... new study finds. The researchers said these biofilms ... The presence of these biofilms may represent an increased ... to predict a person,s risk for the disease, the researchers ... these biofilms may coat the mucus layer of cells lining ...
(Date:12/19/2014)... Dennis Thompson ... News) -- Ebola,s entrance into the United States -- ... League,s mumps outbreak -- have highlighted cracks in the ... a new health policy report released Thursday. Half ... and respond to infectious disease outbreaks. That was the ...
Breaking Medicine News(10 mins):Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4
... Researchers have for the first time cleared an important ... Neutropenia (SCN), a deadly disease characterized by a deficiency ... cell important to fighting infection and disease. A research ... in the March 14 Immunity the first evidence of ...
... total retail drug,store sales of $379 million for the four-week period ended February 28,2008, an increase of 3.2 ... 4 weeks ended February ... $379 Increase from comparable prior ... ...
... March 6, 2008 A study released this ... Healthcare System in California shows that non-polypoid colorectal neoplasms ... than previously thought and may have a greater association ... commonly diagnosed colorectal polyp. The study appears in the ...
... 6 Statement from Chuck,Mohan, executive director ... on reports of possible links between childhood ... scientific studies documenting that childhood,vaccinations cause or ... scientific research in this area. Mitochondrial diseases ...
... 6 SpectraCell Laboratories, Inc.,announced that the company ... its scientific,staff as Manager of Research & Development., ... the University of Texas,M.D. Anderson Cancer Center. He ... cellular and molecular biology research, as well as ...
... Refusing Plan Despite No Change in Payments, HARRISBURG, ... it will conduct fifteen additional informational,sessions at five locations ... Pennsylvania select the best Medicare plan and continue health,care ... continue through March 14,in King of Prussia, Exton, Blue ...
Cached Medicine News:Health News:Function of molecular switch pinpointed in severe congenital neutropenia 2Health News:Function of molecular switch pinpointed in severe congenital neutropenia 3Health News:Longs Reports Preliminary February Retail Drug Store Sales 2Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories 2Health News:Meetings Set in Southeast PA to Help State Retirees Choose Best Plan to Continue Health Care Benefits 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: